Accuray | ARAY - Gross Profit On Sales

Stock Price
0.54
Daily Change
-0.02 -3.08%
Monthly
-33.90%
Yearly
-74.63%
Q1 Forecast
0.52

Accuray reported $41.89M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 38.86M 1.05M Feb/2025
Artivion USD 61.01M 2.32M Sep/2024
AtriCure USD 105.34M 4M Dec/2025
Boston Scientific USD 3.68B 136M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 545.88M 410.83M Dec/2024
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025